1. Home
  2. DHC vs HUMA Comparison

DHC vs HUMA Comparison

Compare DHC & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diversified Healthcare Trust of Beneficial Interest

DHC

Diversified Healthcare Trust of Beneficial Interest

HOLD

Current Price

$4.71

Market Cap

856.4M

Sector

Real Estate

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$1.32

Market Cap

236.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DHC
HUMA
Founded
1998
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
856.4M
236.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DHC
HUMA
Price
$4.71
$1.32
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$5.25
$10.13
AVG Volume (30 Days)
815.9K
4.3M
Earning Date
11-03-2025
11-12-2025
Dividend Yield
0.85%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,537,901,000.00
$1,571,000.00
Revenue This Year
$4.79
N/A
Revenue Next Year
$3.32
$731.05
P/E Ratio
N/A
N/A
Revenue Growth
4.10
N/A
52 Week Low
$2.00
$1.09
52 Week High
$4.99
$6.77

Technical Indicators

Market Signals
Indicator
DHC
HUMA
Relative Strength Index (RSI) 53.21 47.73
Support Level $4.65 $1.21
Resistance Level $4.99 $1.32
Average True Range (ATR) 0.14 0.07
MACD -0.02 0.02
Stochastic Oscillator 44.33 55.88

Price Performance

Historical Comparison
DHC
HUMA

About DHC Diversified Healthcare Trust of Beneficial Interest

Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs. Majority of revenue is from SHOP segment.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: